GlassScriptPhysician profile
Troy C Diehl
NPI 1457480287
$52,696.18
in general payments reported to CMS, 2019-2025
29 companies · $958 in 2025
The $958 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47K · 2020: $381 · 2021: $417 · 2022: $2,592 · 2023: $256 · 2024: $995 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,522 · Travel and Lodging: $641 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,521.72 |
| Travel and Lodging | $640.90 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fuse Medical, INC. | $46,025.88 | 2019 | |
| Zimmer Biomet Holdings, INC. | $2,296.28 | 2019-2025 | Oxford, Tapestry |
| Arthrex, INC. | $1,689.20 | 2022-2024 | |
| Pylant Medical | $376.26 | 2020-2024 | |
| Linvatec Corporation | $353.51 | 2025 | Biobrace 23mm |
| Smith+Nephew, INC. | $312.11 | 2020-2025 | Rf20000 |
| Horizon Therapeutics Plc | $190.75 | 2019-2022 | |
| Depuy Synthes Sales INC. | $189.53 | 2021-2025 | Monovisc, Orthovisc |
| Miach Orthopaedics, INC. | $159.04 | 2023 | |
| Ferring Pharmaceuticals INC. | $134.08 | 2019-2023 | Euflexxa |
| Abbott Laboratories | $133.76 | 2019-2021 | |
| Davol INC. | $113.54 | 2021-2024 | Arista Ah Flexitip |
| Bioventus LLC | $112.68 | 2019-2025 | Xcell, Gelsyn-3 |
| Medacta USA, INC. | $80.11 | 2024-2025 | Gmk Sphere |
| Vericel Corporation | $68.40 | 2022-2025 | Maci |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $61.22 | 2024-2025 | Hymovis, Triluron, Hyalgan |
| Vertex Pharmaceuticals Incorporated | $57.62 | 2025 | |
| Pacira Therapeutics, INC. | $46.05 | 2020 | |
| Baudax Bio INC. | $39.69 | 2021 | |
| Cpm Medical Consultants, LLC | $36.24 | 2019 | |
| Becton, Dickinson and Company | $33.10 | 2025 | Arista |
| Orthofix Medical, INC. | $29.92 | 2019-2025 | Physio-Stim |
| Stryker Corporation | $29.36 | 2023-2024 | Inspace, Cinchlock |
| Kerecis Limited | $25.82 | 2022 | |
| Medtronic, INC. | $24.11 | 2024 | Aquamantys(Tm) |
| Innovation Technologies INC | $23.18 | 2025 | Irrisept |
| Medtronic USA, INC. | $22.62 | 2020 | |
| Myoscience INC. | $18.02 | 2019 | |
| Amgen INC. | $14.10 | 2024 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Diehl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.